Portal:ExRNA/FeaturedPathways
From WikiPathways
(Difference between revisions)
(added new pathway) |
(adding new pathways) |
||
| Line 61: | Line 61: | ||
|width=100px|{{#pwImage:Pathway:WP4284|250px||Ultraconserved region 339 modulation of tumor suppressor microRNAs in cancer}} | |width=100px|{{#pwImage:Pathway:WP4284|250px||Ultraconserved region 339 modulation of tumor suppressor microRNAs in cancer}} | ||
[https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5703849/ Vannini et al. Transcribed ultraconserved region 339 promotes carcinogenesis by modulating tumor suppressor microRNAs] | [https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5703849/ Vannini et al. Transcribed ultraconserved region 339 promotes carcinogenesis by modulating tumor suppressor microRNAs] | ||
| + | [https://www.ncbi.nlm.nih.gov/pubmed/29158817 Bei et al. Extracellular Vesicles in Cardiovascular Theranostics.] | ||
| + | |width=100px|{{#pwimage:Pathway:WP4300|250px||Extracellular vesicles in the crosstalk of cardiac cells}} | ||
| + | |- | ||
| + | [https://www.ncbi.nlm.nih.gov/pubmed/28844715 Datta et al. Manumycin A suppresses exosome biogenesis and secretion via targeted inhibition of Ras/Raf/ERK1/2 signaling and hnRNP H1 in castration-resistant prostate cancer cells] | ||
| + | |width=100px|{{#pwimage:Pathway:WP4301|250px||Inhibition of exosome biogenesis and secretion by Manumycin A in CRPC cells}} | ||
|width=100px|{{#pwimage:Pathway:WP2261|250px||Signaling Pathways in Glioblastoma}} | |width=100px|{{#pwimage:Pathway:WP2261|250px||Signaling Pathways in Glioblastoma}} | ||
| + | |width=100px|{{#pwImage:Pathway:WP1991|250px||SRF and miRs in Smooth Muscle Differentiation and Proliferation}} | ||
|- | |- | ||
|width=100px|{{#pwImage:Pathway:WP2029|250px||Cell Differentiation}} | |width=100px|{{#pwImage:Pathway:WP2029|250px||Cell Differentiation}} | ||
| Line 94: | Line 100: | ||
[http://diana.imis.athena-innovation.gr/DianaTools/index.php?r=tarbase/index TarBase] | [http://diana.imis.athena-innovation.gr/DianaTools/index.php?r=tarbase/index TarBase] | ||
|- | |- | ||
| - | |width=100px|{{# | + | |width=100px|{{#pwimage:Pathway:WP2012|250px||miRs in Muscle Cell Differentiation}} |
|width=100px|{{#pwimage:Pathway:WP2910|250px||Mecp2 and Associated Rett Syndrome}} | |width=100px|{{#pwimage:Pathway:WP2910|250px||Mecp2 and Associated Rett Syndrome}} | ||
|width=100px|{{#pwImage:Pathway:WP2011|250px||REBF and miR33 in cholesterol and lipid homeostasis}} | |width=100px|{{#pwImage:Pathway:WP2011|250px||REBF and miR33 in cholesterol and lipid homeostasis}} | ||
| Line 111: | Line 117: | ||
|width=100px|{{#pwImage:Pathway:WP2002|250px||miR-targeted genes in epithelium - TarBase}} | |width=100px|{{#pwImage:Pathway:WP2002|250px||miR-targeted genes in epithelium - TarBase}} | ||
[http://diana.imis.athena-innovation.gr/DianaTools/index.php?r=tarbase/index TarBase] | [http://diana.imis.athena-innovation.gr/DianaTools/index.php?r=tarbase/index TarBase] | ||
| - | |||
|} | |} | ||
Revision as of 20:51, 31 May 2018
|
Image does not exist T-Cell Receptor and Co-stimulatory Signaling |
Image does not exist IL1 and megakaryotyces in obesity |
Image does not exist RNA interference Ozpolat et al. Liposomal siRNA nanocarriers for cancer therapy Thomas et al. Eri1: a conserved enzyme at the crossroads of multiple RNA-processing pathways |
Image does not exist Extracellular vesicle-mediated signaling in recipient cells |
|
Image does not exist TCA Cycle Nutrient Utilization and Invasiveness of Ovarian Cancer |
Image does not exist mir34a and TGIF2 in osteoclastogenesis |
Image does not exist mir219 in Oligodendrocyte Differentiation and Myelination |
Image does not exist Apoptosis-related network due to altered Notch3 in ovarian cancer |
|
Image does not exist miR-222 in Exercise-Induced Cardiac Growth |
Image does not exist Hypoxia-mediated EMT and Stemness |
Image does not exist DDX1 as a regulatory component of the Drosha microprocessor |
Image does not exist EV release from cardiac cells and their functional effects Danielson and Das, Extracellular Vesicles in Heart Disease: Excitement for the Future? |
|
Image does not exist Rac1/Pak1/p38/MMP-2 pathway Gonzalez-Villasana et al. Rac1/Pak1/p38/MMP-2 Axis Regulates Angiogenesis in Ovarian Cancer |
Image does not exist eIF5A regulation in response to inhibition of the nuclear export system Miyake et al. XPO1/CRM1 Inhibition Causes Antitumor Effects by Mitochondrial Accumulation of eIF5A |
Image does not exist MFAP5-mediated ovarian cancer cell motility and invasiveness |
Image does not exist LncRNA-mediated mechanisms of therapeutic resistance Parasramka et al. Long non-coding RNAs as novel targets for therapy in hepatocellular carcinoma |
|
Image does not exist ApoE and miR-146 in inflammation and atherosclerosis |
Image does not exist miR-148a/miR-31/FIH1/HIF1α-Notch signaling in glioblastoma |
Image does not exist mir-124 predicted interactions with cell cycle and differentiation |
Image does not exist miR-517 relationship with ARCN1 and USP1 |
|
Image does not exist miR-509-3p alteration of YAP1/ECM axis |
Image does not exist H19 action Rb-E2F1 signaling and CDK-β-catenin activity |
Image does not exist mir-193a and MVP in colon cancer metastasis Teng et al. H19 MVP-mediated exosomal sorting of miR-193a promotes colon cancer progression |
Image does not exist miRNA regulation of p53 pathway in prostate cancer |
|
Image does not exist miRNA regulation of prostate cancer signaling pathways |
Image does not exist LncRNA involvement in canonical Wnt signaling and colorectal cancer Shen et al. To Wnt or Lose: The Missing Non-Coding Linc in Colorectal Cancer |
Image does not exist Ultraconserved region 339 modulation of tumor suppressor microRNAs in cancer Vannini et al. Transcribed ultraconserved region 339 promotes carcinogenesis by modulating tumor suppressor microRNAs Bei et al. Extracellular Vesicles in Cardiovascular Theranostics. |
Image does not exist Extracellular vesicles in the crosstalk of cardiac cells |
|
Image does not exist Inhibition of exosome biogenesis and secretion by Manumycin A in CRPC cells |
Image does not exist Signaling Pathways in Glioblastoma |
Image does not exist SRF and miRs in Smooth Muscle Differentiation and Proliferation | |
|
Image does not exist Cell Differentiation |
Image does not exist Endoderm Differentiation |
Image does not exist Ectoderm Differentiation |
Image does not exist Mesodermal Commitment Pathway |
|
Image does not exist ErbB Signaling Pathway |
Image does not exist Mir302-367 Promoting Cardiomyocyte Proliferation |
Image does not exist Alzheimers Disease |
Image does not exist Parkinsons Disease |
|
Image does not exist MicroRNAs in cardiomyocyte hypertrophy |
Image does not exist Integrated Lung Cancer Pathway |
Image does not exist miRNA Biogenesis |
Image does not exist miRNA targets in ECM and membrane receptors |
|
Image does not exist Fluoropyrimidine Activity |
Image does not exist miRNAs involved in DNA damage response |
Image does not exist Metastatic Brain Tumor |
Image does not exist Regulatory RNA pathways |
|
Image does not exist Spinal Cord Injury |
Image does not exist miRNA Regulation of DNA Damage Response |
Image does not exist Parkinsons Disease Pathway (Mus musculus) |
Image does not exist Hepatitis C and Hepatocellular Carcinoma |
|
Image does not exist Metastatic brain tumor |
Image does not exist Role of Osx and miRNAs in tooth development |
Image does not exist miR-127 in mesendoderm differentiation |
Image does not exist miR-targeted genes in adipocytes - TarBase |
|
Image does not exist miRs in Muscle Cell Differentiation |
Image does not exist Mecp2 and Associated Rett Syndrome |
Image does not exist REBF and miR33 in cholesterol and lipid homeostasis |
Image does not exist TarBasePathway |
|
Image does not exist miR-targeted genes in lymphocytes - TarBase |
Image does not exist miR-targeted genes in muscle cell - TarBase |
Image does not exist miR-targeted genes in leukocytes - TarBase |
Image does not exist miR-targeted genes in squamous cell - TarBase |
|
Image does not exist miR-targeted genes in epithelium - TarBase |
